AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sita OD MSR 50/500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sita OD MSR 50/500 Tablet ER

Sita OD MSR 50/500 Extended-Release tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, potentially lowering the risk of cardiovascular events such as heart attacks and strokes. Sita OD MSR 50/500 ER may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a healthy diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal upset. Consistent daily dosing at the same time each day maximizes efficacy; discontinuation should only occur under your physician's guidance. Adherence to your prescribed diet and exercise regimen is crucial for effective diabetes management. Common side effects include diarrhea, nausea, vomiting, stomach discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn how to recognize and treat this condition. This medication isn't appropriate for all individuals. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before starting treatment. Pregnant or lactating women should consult their physician. Drug interactions are possible; disclose all medications to ensure safe use. Alcohol should be limited due to its potential to lower blood sugar. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sita OD MSR 50/500 Tablet ER

Managing type 2 diabetes

Major Benefits of Sita OD MSR 50/500 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sita OD MSR 50/500 Extended-Release tablets should be administered with a meal.

Common Side effects of Sita OD MSR 50/500 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sita OD MSR 50/500 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sita OD MSR 50/500 Tablet ER whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.

How Sita OD MSR 50/500 Tablet ER works:

Sita OD MSR 50/500 Extended-Release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Sita OD MSR 50/500 Tablet ER is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sita OD MSR 50/500 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescription. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sita OD MSR 50/500 Tablet is likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sita OD MSR 50/500 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Sita OD MSR 50/500 Extended-Release tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sita OD MSR 50/500 Tablet ER :

Should you forget a dose of Sita OD MSR 50/500 Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sita OD MSR 50/500 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sita OD MSR 50/500 Tablet ER

Sita OD MSR 50/500 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sita OD MSR 50/500 Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sita OD MSR 50/500 Tablet ER may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Sita OD MSR 50/500 Tablet ER is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol with Sita OD MSR 50/500 Tablet ER is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (Sita OD MSR 50/500 Tablet ER) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sita OD MSR 50/500 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sita OD MSR 50/500 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to Sita OD MSR 50/500 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol with Sita OD MSR 50/500 Tablet ER is unsafe and may heighten the risk of lactic acidosis.
Sita OD MSR 50/500 Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sita OD MSR 50/500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sita OD MSR 50/500 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sita OD MSR 50/500 Tablet ER may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Sita OD MSR 50/500 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sita OD MSR 50/500 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Yes, Sita OD MSR 50/500 Tablet ER (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged use of Sita OD MSR 50/500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplementation of vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sita OD MSR 50/500 Tablet...
99
MRP 115
13% off